Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 04 entities : Sanofi save search
Sangamo Therapeutics Reports Recent Business and Clinical Highlights and Third Quarter 2021 Financial Results
Published: 2021-11-04 (Crawled : 02:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: 7.39%
H: 0.0%
C: 0.0%
financial results results
Verastem Oncology Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress
Published: 2021-11-04 (Crawled : 01:00) - biospace.com/
VSTM | $9.29 -3.33% -3.44% 79K
|
Health Technology
|
| O: -0.7%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
financial results results
Cellectis Provides Business Update and Reports Financial Results for Third Quarter and First Nine Months 2021
Published: 2021-11-04 (Crawled : 21:00) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -1.65%
H: 0.0%
C: 0.0%
RLAY | $6.34 7.46% 6.94% 1.7M
|
Health Technology
|
| O: 0.03%
H: 1.35%
C: -2.39%
CLLS | News | $2.53 -3.42% -3.55% 39K
|
Health Technology
|
| O: -5.54%
H: 7.67%
C: 5.43%
financial results results
The Talent Enterprise: The Thriving Index® is Now a British Psychological Society (BPS) Registered Test
Published: 2021-11-04 (Crawled : 14:15) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
test
NodThera Announces Progress of NT-0796, a Novel NLRP3 Inflammasome Inhibitor, into a Phase 1 First-in-Human Study
Published: 2021-11-04 (Crawled : 14:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
phase 1 phase 2
Escient Pharmaceuticals Announces Data Presentations Highlighting the Preclinical and Clinical Development of EP547 at AASLD The Liver Meeting® Digital Experience 2021
Published: 2021-11-04 (Crawled : 13:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
presentation liver preclinical pre-clinical
Replimune Reports Fiscal Second Quarter Financial Results and Provides Corporate Update
Published: 2021-11-04 (Crawled : 13:00) - globenewswire.com
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 1.37%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
REPL | $6.32 -1.56% -1.58% 630K
|
Health Technology
|
| O: 4.09%
H: 2.47%
C: 0.85%
financial results results
Regeneron Reports Third Quarter 2021 Financial and Operating Results
Published: 2021-11-04 (Crawled : 11:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: 3.07%
H: 0.39%
C: -1.46%
results
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.